Trial Profile
A Randomized Controlled Trial Comparing High-dose vs. Standard Influenza Vaccine in Adult Solid Organ Transplant Recipients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Oct 2020
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 21 Oct 2020 Status changed from active, no longer recruiting to completed.
- 24 Sep 2019 Planned End Date changed from 1 Jun 2019 to 1 Jun 2021.
- 09 Oct 2018 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.